Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial

Try Barchart for Free

UPGRADE

Advanced search

or

Watchlist | Portfolio | Dashboard

quotes
- Price Overview
- Performance Report
charts
- Interactive Chart
- Snapshot Chart
technicals
company
analysts
- Earnings Estimates
- Analyst Ratings
financials

Atyr Pharma Inc (LIFE)

Atyr Pharma Inc (LIFE)

N/A x N/A N/A x N/A

Post-market by (Cboe BZX)

1.9000 +0.0500 (+2.70%) 06/04/24 [NASDAQ]

N/A x N/A N/A x N/A

Post-market 1.9000 unch (unch) -

News & Headlines for Tue, Jun 4th, 2024

Atyr Pharma: Q1 Earnings Snapshot AP - Thu May 2, 2024

Atyr Pharma: Q1 Earnings Snapshot

Atyr Pharma: Q4 Earnings Snapshot AP - Thu Mar 14, 2024

Atyr Pharma: Q4 Earnings Snapshot

Atyr Pharma: Q3 Earnings Snapshot AP - Thu Nov 9, 2023

Atyr Pharma: Q3 Earnings Snapshot

Atyr Pharma: Q2 Earnings Snapshot AP - Wed Aug 9, 2023

Atyr Pharma: Q2 Earnings Snapshot

Atyr Pharma: Q1 Earnings Snapshot AP - Tue May 9, 2023

Atyr Pharma: Q1 Earnings Snapshot

Atyr Pharma: Q4 Earnings Snapshot AP - Thu Mar 9, 2023

Atyr Pharma: Q4 Earnings Snapshot

Atyr Pharma: Q3 Earnings Snapshot AP - Thu Nov 10, 2022

Atyr Pharma: Q3 Earnings Snapshot

aTyr Pharma Receives FDA Fast Track Designation for Efzofitimod (ATYR1923) for Treatment of Pulmonary Sarcoidosis Globe Newswire - Thu Aug 11, 2022

Company is investigating efzofitimod in global pivotal Phase 3 EFZO-FIT™ study in pulmonary sarcoidosis patients...

Love Hemp Group PLC Announces Directorate Changes and Trading Suspension Update ACCESS Newswire - Fri Jul 8, 2022

LONDON, UK / ACCESSWIRE / July 8, 2022 / Love Hemp Group PLC (AQSE:LIFE)(OTCQB:WRHLF) the brand-led consumer goods company focussed on CBD health and wellness solutions, gives an update regarding its Board...

aTyr Pharma Announces FGFR4 as Receptor Target for AARS tRNA Synthetase Fragment Globe Newswire - Tue Jun 14, 2022

Poster to be presented at the Keystone Symposia on Tissue Fibrosis and Repair. Second tRNA synthetase receptor identified from company’s platform. ...

Want to use this as
your default charts setting?

Save this setup as a Chart Templates

Switch the Market flag

for targeted data from your country of choice.

Open the menu and switch the
Market flag for targeted data from your country of choice.

Want Streaming Chart Updates?

Switch your Site Preferences
to use Interactive Charts

Need More Chart Options?

Right-click on the chart to open the Interactive Chart menu.

Use your up/down arrows to move through the symbols.

Free Barchart Webinar

Value Investing Philosophies: Graham, Buffett, Bogle, and EMH in Perspective